Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2023

May 19, 2023

31971_dirs_2023-05-19_246c6b97-32a5-4c35-8b2d-d584fced8291.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2023-05-18

Reporting Person: Peters Stanley W III (VP GM Advanced Surgery)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-05-18 Common Stock M 1500 $41.93 Acquired 1563 Direct
2023-05-18 Common Stock S 1500 $119.2407 Disposed 63 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-05-18 Options To Purchase Common Stock $41.93 M 1500 Disposed 2027-03-01 Common Stock (1500) Direct

Footnotes

F1: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.